Email Alert RSS
Volume 13 Issue 4
Jul.  2022
Turn off MathJax
Article Contents
Abstract
References
Related Articles
QIU Luhong, LIU Yingxian, XU Xiqi. Nonnegligible Myocarditis: Insights from 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 530-534. DOI: 10.12290/xhyxzz.2022-0077
Citation: QIU Luhong, LIU Yingxian, XU Xiqi. Nonnegligible Myocarditis: Insights from 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 530-534. DOI: 10.12290/xhyxzz.2022-0077
shu

Nonnegligible Myocarditis: Insights from 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

  • Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

Funds: 

National Natural Science Foundation of China 82000470

More Information
  • Corresponding author:

    XU Xiqi, E-mail: xuxiqi0928@163.com

  • Received Date: February 22, 2022
  • Accepted Date: March 16, 2022
  • Available Online: April 11, 2022
  • Issue Publish Date: July 29, 2022
    Graphical Abstract
    • Abstract
  • In September 2021, Eur Heart J published the 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure, making important updates to the 2016 version. In the new guidelines, myocarditis is identified as a special clinical condition in heart failure that should be given more attention than before. Based on the current clinical practice of myocarditis management in China, this article aims to provide a comprehensive interpretation of the myocarditis section in the new guidelines, with the hope of improving the diagnosis and treatment of this disease.
    • FullText(HTML)
    • References (15)
  • [1]
    McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. Eur Heart J, 2021, 42: 3599-3726.
    [2]
    Dai H, Lotan D, Much AA, et al. Global, Regional, and National Burden of Myocarditis and Cardiomyopathy, 1990—2017[J]. Front Cardiovasc Med, 2021, 8: 610989. DOI: 10.3389/fcvm.2021.610989
    [3]
    Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990—2013: a systematic analysis for the Global Burden of Disease Study 2013[J]. Lancet, 2015, 386: 743-800.
    [4]
    Heymans S, Eriksson U, Lehtonen J, et al. The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy[J]. J Am Coll Cardiol, 2016, 68: 2348-2364. DOI: 10.1016/j.jacc.2016.09.937
    [5]
    Merken J, Hazebroek M, Van Paassen P, et al. Immunosuppressive Therapy Improves Both Short- and Long-Term Prognosis in Patients With Virus-Negative Nonfulminant Inflammatory Cardiomyopathy[J]. Circ Heart Fail, 2018, 11: e004228. DOI: 10.1161/CIRCHEARTFAILURE.117.004228
    [6]
    Das M, Bristow MR, Chung MK. The Essential Vulner-ability of Human Cardiac Myocytes to SARS-CoV-2[J]. JACC Basic Transl Sci, 2021, 6: 346-349. DOI: 10.1016/j.jacbts.2021.02.010
    [7]
    Grün S, Schumm J, Greulich S, et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery[J]. J Am Coll Cardiol, 2012, 59: 1604-1615. DOI: 10.1016/j.jacc.2012.01.007
    [8]
    Yeung C, Baranchuk A. Diagnosis and Treatment of Lyme Carditis: JACC Review Topic of the Week[J]. J Am Coll Cardiol, 2019, 74: 717-726. DOI: 10.1016/j.jacc.2019.08.865
    [9]
    Moslehi JJ, Salem JE, Sosman JA, et al. Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis[J]. Lancet, 2018, 391: 933.
    [10]
    Palaskas N, Lopez-Mattei J, Durand JB, et al. Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment[J]. J Am Heart Assoc, 2020, 9: e013757.
    [11]
    Caforio AL, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases[J]. Eur Heart J, 2013, 34: 2636-2648, 2648a-2648d.
    [12]
    Staudt A, Schäper F, Stangl V, et al. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution[J]. Circulation, 2001, 103: 2681-2686.
    [13]
    Ammirati E, Cipriani M, Lilliu M, et al. Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulmi-nant Acute Myocarditis[J]. Circulation, 2017, 136: 529-545.
    [14]
    Gannon MP, Schaub E, Grines CL, et al. State of the art: Evaluation and prognostication of myocarditis using cardiac MRI[J]. J Magn Reson Imaging, 2019, 49: e122-e131.
    [15]
    Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy[J]. N Engl J Med, 2000, 342: 1077-1084.
    • Related Articles

  • Related Articles

    [1]Society of Gynecologic Oncology, Chinese Medical Association, Branch of Colposcopy and Cervical Pathology, China Healthy Birth Science Association, Professional Committee on Cancer Prevention and Control, Chinese Preventive Medicine Association, Specialized Committee on Cervical Cancer Prevention and Control Research, China Maternal and Child Health Research Association, National Collaborative Group for Cervical Cancer Prevention and Treatment, China Cancer Foundation, Committee on Cervical Cancer, China Anti-Cancer Association, Branch of Obstetric and Gynecological Health Medicine, China International Exchange and Promotive Association for Medical and Health Care. Preventive Human Papilloma Virus Vaccine Guidelines for Clinical Use in China(2025 edition)[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(2): 350-360. DOI: 10.12290/xhyxzz.2025-0246
    [2]YIXI Jinba, WANG Gaoxue, BASANG Ciren, GASONG Zhuoga, PU Zhi, CIREN Yangjin, BIAN Zhen, LIU Zhijuan, DU Juan. HPV Survey and Analysis of Women in Xizang[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0914
    [3]CHEN Yuqing, LI Jinming. Virological Characteristics of the Omicron Variant: Key Mutations, Pathogenicity, and Immune Escape[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 945-952. DOI: 10.12290/xhyxzz.2023-0139
    [4]WANG Xiaodan, ZHANG Zhan, LIU Zhaohui. Analysis of Influencing Factors for High-risk Human Papillomavirus Infection[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(1): 153-158. DOI: 10.12290/xhyxzz.2022-0193
    [5]LIANG Li. Interpretation on The Consensus Among Chinese Experts About Acquisition and Quality Control of Digital Pathological Images in Cervical Liquid Based Cytology[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 571-573. DOI: 10.12290/xhyxzz.2022-0100
    [6]LIU Yanting, ZHANG Lu, CHEN Miao, ZHANG Yan, WEI Chong, PAN Boju, ZHAO Jiawei. A Case of Small B-cell Lymphocytic Lymphoma Diagnosed One Year after Evans Syndrome[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 423-426. DOI: 10.12290/xhyxzz.20200063
    [7]Gynecological Oncology Society of Chinese Medical Association, Chinese Society for Colposcopy and Cervical Pathology. Chinese Expert Consensus on Clinical Application of Human Papilloma Virus Vaccine[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(2): 189-201. DOI: 10.12290/xhyxzz.2021-0082
    [8]Dong XU, Feng-chun ZHANG. Systemic Lupus Erythematosus, Human Papilloma Virus Infection and Vaccine[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 252-257. DOI: 10.3969/j.issn.1674-9081.20200042
    [9]Hong-zhi GUAN, Lin CHEN, Zhi-yong LIANG, Ding-rong ZHONG, Jian LI, Wei CUI, Min QIAN, Hai-tao REN, Qing LING, Xuan WANG, Yan-huan ZHAO, Yu-pu GUO. Role of Cerebrospinal Fluid Cytology in Diagnosis of Primary Central Nervous System Lymphoma[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(3): 273-278. DOI: 10.3969/j.issn.1674-9081.2012.03.006
    [10]Lu-lu SUN, Dong-yan CAO, Jia-xin YANG, Mei-lu BIAN, Li-hui WEI, Li YANG, Ning-hai CHENG, Yi YANG, You-fang WANG, Xue-mei CHENG, Li-jun HU, Jie CHEN, Jing-he LANG, Keng SHEN. Value-based Medicine of Loop Electrosurgical Excision Procedure and CO2 Laser Vaporization for Cervical Intraepithelial Neoplasia 2[J]. Medical Journal of Peking Union Medical College Hospital, 2011, 2(2): 129-133. DOI: 10.3969/j.issn.1674-9081.2011.02.008

  • Cited by

    Periodical cited type(2)

    1. 赵世豪，王俊涛，陈宽，王茜，王红玲，王文慧，梁宇聪，王祥麒. 国医大师唐祖宣治疗前列腺癌经验. 中医学报. 2025(02): 377-382 .
    2. 李宗霖，卢强，李远伟. 尿液代谢组学在前列腺癌中的应用研究进展. 中国现代医学杂志. 2024(08): 40-44 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1000) PDF downloads (139) Cited by(2)
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close